Table 2.

2-Year Estimates of Time-to-Event End Points

End Point	Patient Group
	All		Stages IIB to IVB
	2-Year Estimate	95% CI	2-Year Estimate	95% CI
Local progression-free interval	92.6	86.3 to 98.9	91.2	83.8 to 98.6
Regional progression-free interval	90.8	83.6 to 97.9	89.2	81.0 to 97.5
Locoregional progression-free interval	89.3	81.7 to 96.9	87.5	78.7 to 96.3
Distant metastases–free interval	84.7	75.9 to 93.5	82.1	72.0 to 92.3
Progression-free survival	72.7	61.9 to 83.5	68.0	55.7 to 80.2
Overall survival	80.2	70.5 to 89.8	76.7	65.6 to 87.8